25 April 2005
CSD500 Manufacturing trials
Futura Medical plc ("Futura" or “the Company”), the AIM-listed pharmaceutical and medical device group that develops innovative products for the sexual healthcare market, today announces completion of initial manufacturing trials of its Condom Safety Device (“CSD500”).
This manufacturing trial follows encouraging stability and compatibility results on the gel in laboratory studies and will generate essential data to confirm the laboratory data. This will facilitate the submission of an application to EU regulators for CSD500 marketing authorisation later in the year.
CSD500 is a latex condom incorporating within its teat a gel to help healthy men maintain an erection throughout intercourse, thereby reducing the likelihood of condom slippage.
James Barder, Chief Executive of Futura, said: “This is an important step towards the completion of the dossier for CSD500.”